As always, the FDA tackled major challenges in 2019 — from streamlining drug approvals to promoting data integrity, combatting drug shortages, fighting the opioid epidemic and more. How well did the agency fare?
Our December cover story will take a close look at some of the biggest regulatory issues of 2019. But we also want your take on what the FDA got right — and where it needs to improve.
Take our quick two-question survey and give us your thoughts on the FDA’s biggest wins and fails of 2019 for a chance to get quoted in our December issue. Current survey results from other readers will be available instantly after you click “Submit” — and final results will appear in our December issue.
Latest from Regulatory Guidance
Latest from Regulatory Guidance
